Atrial cardiomyopathy: An entity of emerging interest in the clinical setting

Boriani, Giuseppe; Gerra, Luigi; Mantovani, Marta; Tartaglia, Enrico; Mei, Davide A; Imberti, Jacopo F; Vitolo, Marco; Bonini, Niccolò

doi:10.1016/j.ejim.2023.10.023

European Journal of Internal Medicine

2023

DOI: 10.1016/j.ejim.2023.10.023

|View full text |Cite

Atrial cardiomyopathy: An entity of emerging interest in the clinical setting

Giuseppe Boriani,

Luigi Gerra,

Marta Mantovani

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

References 110 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Detection of subclinical atrial fibrillation with cardiac implanted electronic devices: What decision making on anticoagulation after the NOAH and ARTESiA trials?

Boriani,

Gerra,

Mei

et al. 2024

European Journal of Internal Medicine

View full text Add to dashboard Cite

Detection of subclinical atrial fibrillation with cardiac implanted electronic devices: What decision making on anticoagulation after the NOAH and ARTESiA trials?

Boriani,

Gerra,

Mei

et al. 2024

European Journal of Internal Medicine

View full text Add to dashboard Cite

Atrial High-Rate Episodes and Subclinical Atrial Fibrillation: State of the Art and Clinical Questions with Complex Solutions

Griffith Brookles,

De Ponti,

Russo

et al. 2024

Rev. Cardiovasc. Med.

View full text Add to dashboard Cite

Atrial high-rate episodes (AHREs) and subclinical atrial fibrillation (AF) are frequently registered in asymptomatic patients with cardiac implantable electronic devices (CIEDs) and insertable cardiac monitors (ICMs). While an increased risk of thromboembolic events (e.g., stroke) and benefits from anticoagulation have been widely assessed in the setting of clinical AF, concerns persist about optimal clinical management of subclinical AF/AHREs. As a matter of fact, an optimal threshold of subclinical episodes’ duration to predict stroke risk is still lacking and recently published randomized clinical trials assessing the impact of anticoagulation on thromboembolic events in this specific setting have shown contrasting results. The aim of this review is to summarize current evidence regarding classification and clinical impact of subclinical AF/AHREs and to discuss the latest evidence regarding the potential benefit of anticoagulation in this setting, highlighting which clinical questions are still unanswered.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Atrial cardiomyopathy: An entity of emerging interest in the clinical setting

Cited by 2 publications

References 110 publications

Detection of subclinical atrial fibrillation with cardiac implanted electronic devices: What decision making on anticoagulation after the NOAH and ARTESiA trials?

Detection of subclinical atrial fibrillation with cardiac implanted electronic devices: What decision making on anticoagulation after the NOAH and ARTESiA trials?

Atrial High-Rate Episodes and Subclinical Atrial Fibrillation: State of the Art and Clinical Questions with Complex Solutions

Contact Info

Product

Resources

About